Trademark applications and grants for Glaxo Group L T D. Glaxo Group L T D has 4581 trademark applications. The latest application filed is for "XIMANDER"
Patent Application | Date |
---|---|
COMBINATIONS OF A MUSCARINIC RECEPTOR ANTAGONIST AND A BETA-2 ADRENORECEPTOR AGONIST 20220047565 - 17/514685 BAKER; Darrell ;   et al. | 2022-02-17 |
MODIFIED PROTEINS AND PEPTIDES 20210017293 - 17/014441 Ashman; Claire ;   et al. | 2021-01-21 |
ANTIGEN BINDING PROTEINS TO ONCOSTATIN M (OSM) 20210017270 - 16/924628 BEMBRIDGE; Gary Peter ;   et al. | 2021-01-21 |
Dry Powder Inhalation Drug Products Exhibiting Moisture Control Properties and Methods of Administering the Same 20200315919 - 16/829484 ASWANIA; Osama Ahmed ;   et al. | 2020-10-08 |
ANTI-SERUM ALBUMIN BINDING VARIANTS 20200283512 - 16/879238 DE ANGELIS; Elena ;   et al. | 2020-09-10 |
NCAGE Code | KCF54 | GLAXO GROUP LTD |
CAGE Code | KCF54 | GLAXO GROUP LTD |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.